Caixin Industry Fund logo

Caixin Industry Fund

Asia, Hunan, China, Changshan

Description

Caixin Industry Fund is an investment platform for Hunan Province to innovate the financial investment and financing system reform.

Investor Profile

Caixin Industry Fund has backed more than 2 startups, with 1 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C, Series A rounds (top funding stages).
  • Majority of deals are located in China.
  • Strong thematic focus on Biopharma, Biotechnology, Health Care.

Stage Focus

  • Series C (50%)
  • Series A (50%)

Country Focus

  • China (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Health Care
  • Manufacturing
  • Medical
  • Pet
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Caixin Industry Fund frequently co-invest with?

Asia Green Fund
Asia, Liaoning, China, Chaoyang
Co-Investments: 1
GL Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Co-Stone Venture Capital
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
U.S.-China Green Fund
Asia, Beijing, China, Beijing
Co-Investments: 1
Hillhouse Ventures
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
GF Qianhe Investment
Asia, Beijing, China, Beijing
Co-Investments: 1
Sherpa Healthcare Partners
Asia, Beijing, China, Beijing
Co-Investments: 1
CLSA
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1
Addor Capital
Asia, Jiangsu, China, Nanjing
Co-Investments: 1
Lilly Asia Ventures
Asia, Shanghai, China, Shanghai
Co-Investments: 1

What are some of recent deals done by Caixin Industry Fund?

PaXini Tech

Shenzhen, Guangdong, China

PaXini Tech is a research and development company for tactile technology and adaptive robots.

Series AJun 18, 2025
Leadsynbio

Suzhou, Jiangsu, China

Leadsynbio is an industrial biotechnology company engaged in the development, production, and sales of health care products.

BiopharmaBiotechnologyHealth CareManufacturingMedicalPet
Series CFeb 8, 2022
Amount Raised: $15,706,477